Financial Times: Improving AML Patient Care

https://acutemyeloidleukaemia.live.ft.com/ 

Discussion topics include:

• What is the experience and unmet needs of AML patients, families and carers, and the challenges they are facing? What is their view of how their diagnosis, treatment, care and support could be improved?

• What are the cost drivers of AML treatment and care, and how might new drugs, diagnostics, new care delivery and other advances help reduce the cost burden, and improve outcomes for patients?

• What needs to be done to improve the care of patients for AML? How could an improved support system for patients, families and carers contribute to lower costs through reduced emergency care and hospitalisation, and result in better outcomes for patients and their support network?

This Financial Times webinar has been funded by and developed in partnership with Daiichi Sankyo, a pharmaceutical company specialising in oncology and speciality medicines.